status: 200
content-location: http://rest.kegg.jp/get/map05014
server: Apache
date: Wed, 15 Oct 2014 15:09:16 GMT
content-type: text/plain

ENTRY       map05014                    Pathway
NAME        Amyotrophic lateral sclerosis (ALS)
DESCRIPTION Amyotrophic lateral sclerosis (ALS) is a progressive, lethal, degenerative disorder of motor neurons. The hallmark of this disease is the selective death of motor neurons in the brain and spinal cord, leading to paralysis of voluntary muscles. Mutant superoxide dismutase 1 (SOD1), as seen in some familial ALS (FALS) cases, is unstable, forming aggregates in the motor neuron cytoplasm, axoplasm and mitochondria. Within mitochondria, mutant SOD1 may interfere with the anti-apoptotic function of Bcl-2, affect mitochondrial import by interfering with the translocation machinery (TOM/TIM), and generate toxic free radicals (ROS). Reactive oxygen species (ROS), produced within mitochondria, inhibit the function of EAAT2, the main glial glutamate transporter protein, responsible for most of the reuptake of synaptically released glutamate. Glutamate excess increases intracellular calcium, which enhances oxidative stress and mitochondrial damage. Mutant SOD1 can also trigger oxidative reactions , which can then cause damage through the formation of hydroxyl radicals or via nitration of tyrosine residues on proteins. Nitration may target neurofilament proteins, affecting axonal transport. Collectively, these mechanisms are predicted to disturb cellular homeostasis, ultimately triggering motor neuron death.
CLASS       Human Diseases; Neurodegenerative diseases
PATHWAY_MAP map05014  Amyotrophic lateral sclerosis (ALS)
DISEASE     H00058  Amyotrophic lateral sclerosis (ALS)
REFERENCE   PMID:16924260
  AUTHORS   Pasinelli P, Brown RH
  TITLE     Molecular biology of amyotrophic lateral sclerosis: insights from genetics.
  JOURNAL   Nat Rev Neurosci 7:710-23 (2006)
REFERENCE   PMID:16723044
  AUTHORS   Goodall EF, Morrison KE
  TITLE     Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment.
  JOURNAL   Expert Rev Mol Med 8:1-22 (2006)
REFERENCE   PMID:17015226
  AUTHORS   Boillee S, Vande Velde C, Cleveland DW
  TITLE     ALS: a disease of motor neurons and their nonneuronal neighbors.
  JOURNAL   Neuron 52:39-59 (2006)
REFERENCE   PMID:11239414
  AUTHORS   Julien JP.
  TITLE     Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded.
  JOURNAL   Cell 104:581-91 (2001)
REFERENCE   PMID:16050975
  AUTHORS   Manfredi G, Xu Z
  TITLE     Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.
  JOURNAL   Mitochondrion 5:77-87 (2005)
REFERENCE   PMID:11870681
  AUTHORS   Hand CK, Rouleau GA
  TITLE     Familial amyotrophic lateral sclerosis.
  JOURNAL   Muscle Nerve 25:135-59 (2002)
REFERENCE   PMID:16713195
  AUTHORS   Barber SC, Mead RJ, Shaw PJ
  TITLE     Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.
  JOURNAL   Biochim Biophys Acta 1762:1051-67 (2006)
REFERENCE   PMID:16026864
  AUTHORS   von Lewinski F, Keller BU
  TITLE     Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS.
  JOURNAL   Trends Neurosci 28:494-500 (2005)
REFERENCE   PMID:10970056
  AUTHORS   Al-Chalabi A, Leigh PN
  TITLE     Recent advances in amyotrophic lateral sclerosis.
  JOURNAL   Curr Opin Neurol 13:397-405 (2000)
REFERENCE   PMID:12531867
  AUTHORS   Guegan C, Przedborski S
  TITLE     Programmed cell death in amyotrophic lateral sclerosis.
  JOURNAL   J Clin Invest 111:153-61 (2003)
REFERENCE   PMID:16909017
  AUTHORS   Bendotti C, Bao Cutrona M, Cheroni C, Grignaschi G, Lo Coco D, Peviani M, Tortarolo M, Veglianese P, Zennaro E
  TITLE     Inter- and intracellular signaling in amyotrophic lateral sclerosis: role of p38 mitogen-activated protein kinase.
  JOURNAL   Neurodegener Dis 2:128-34 (2005)
REFERENCE   PMID:14739060
  AUTHORS   Emerit J, Edeas M, Bricaire F
  TITLE     Neurodegenerative diseases and oxidative stress.
  JOURNAL   Biomed Pharmacother 58:39-46 (2004)
REFERENCE   PMID:11715057
  AUTHORS   Cleveland DW, Rothstein JD
  TITLE     From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS.
  JOURNAL   Nat Rev Neurosci 2:806-19 (2001)
REFERENCE   PMID:15310460
  AUTHORS   Bendotti C, Carri MT
  TITLE     Lessons from models of SOD1-linked familial ALS.
  JOURNAL   Trends Mol Med 10:393-400 (2004)
REFERENCE   PMID:12595144
  AUTHORS   Robertson J, Kriz J, Nguyen MD, Julien JP
  TITLE     Pathways to motor neuron degeneration in transgenic mouse models.
  JOURNAL   Biochimie 84:1151-60 (2002)
REFERENCE   PMID:16603792
  AUTHORS   Bacman SR, Bradley WG, Moraes CT
  TITLE     Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?
  JOURNAL   Mol Neurobiol 33:113-31 (2006)
REFERENCE   PMID:18519638
  AUTHORS   Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, Fukutomi H, Noguchi T, Matsuzawa A, Takeda K, Ichijo H
  TITLE     ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1.
  JOURNAL   Genes Dev 22:1451-64 (2008)
REFERENCE   PMID:14569202
  AUTHORS   Simpson EP, Yen AA, Appel SH
  TITLE     Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis.
  JOURNAL   Curr Opin Rheumatol 15:730-6 (2003)
REFERENCE   PMID:12728264
  AUTHORS   Vila M, Przedborski S
  TITLE     Targeting programmed cell death in neurodegenerative diseases.
  JOURNAL   Nat Rev Neurosci 4:365-75 (2003)
REFERENCE   PMID:11513882
  AUTHORS   Volkel H, Scholz M, Link J, Selzle M, Werner P, Tunnemann R, Jung G, Ludolph AC, Reuter A
  TITLE     Superoxide dismutase mutations of familial amyotrophic lateral sclerosis and the oxidative inactivation of calcineurin.
  JOURNAL   FEBS Lett 503:201-5 (2001)
REFERENCE   PMID:17434459
  AUTHORS   Eve DJ, Dennis JS, Citron BA
  TITLE     Transcription factor p53 in degenerating spinal cords.
  JOURNAL   Brain Res 1150:174-81 (2007)
REFERENCE   PMID:16909020
  AUTHORS   Van Damme P, Dewil M, Robberecht W, Van Den Bosch L
  TITLE     Excitotoxicity and amyotrophic lateral sclerosis.
  JOURNAL   Neurodegener Dis 2:147-59 (2005)
REFERENCE   PMID:17566607
  AUTHORS   Hadano S, Kunita R, Otomo A, Suzuki-Utsunomiya K, Ikeda JE
  TITLE     Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.
  JOURNAL   Neurochem Int 51:74-84 (2007)
REFERENCE   PMID:17409386
  AUTHORS   Kunita R, Otomo A, Mizumura H, Suzuki-Utsunomiya K, Hadano S, Ikeda JE
  TITLE     The Rab5 activator ALS2/alsin acts as a novel Rac1 effector through Rac1-activated endocytosis.
  JOURNAL   J Biol Chem 282:16599-611 (2007)
KO_PATHWAY  ko05014
///
